Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.186,00
0,32%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Centessa Pharmaceuticals PLC (CNTA) Centessa Pharmaceuticals PLC (CNTA) Notizie

Centessa Pharmaceuticals PLC

CNTA
17,98
-0,21 (-1,15%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/11/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:03EDGAR2Form 144 - Report of proposed sale of securities
21/11/202422:33EDGAR2Form 144 - Report of proposed sale of securities
20/11/202422:03EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202413:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:08EDGAR2Form 8-K - Current report
12/11/202413:00GLOBECentessa Pharmaceuticals Reports Financial Results for the..
04/11/202413:30GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
23/10/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202422:07EDGAR2Form 144 - Report of proposed sale of securities
22/10/202422:15EDGAR2Form 144 - Report of proposed sale of securities
21/10/202422:55EDGAR2Form 144 - Report of proposed sale of securities
18/10/202422:01EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
02/10/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202412:00GLOBECentessa Pharmaceuticals Presents Preclinical Data for..
20/9/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202422:01EDGAR2Form 144 - Report of proposed sale of securities
13/9/202422:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/9/202422:00EDGAR2Form 8-K - Current report
13/9/202404:34GLOBECentessa Pharmaceuticals Announces Pricing of Upsized..
13/9/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202422:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202422:04GLOBECentessa Pharmaceuticals Announces $150,000,000 Proposed..
11/9/202422:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
10/9/202422:06EDGAR2Form 144 - Report of proposed sale of securities
10/9/202413:08EDGAR2Form 8-K - Current report
10/9/202413:00GLOBECentessa Announces Positive Interim Phase 1 Clinical Data..
27/8/202414:00GLOBECentessa Pharmaceuticals Announces Late-Breaking Poster..
23/8/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:13EDGAR2Form 144 - Report of proposed sale of securities
22/8/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202422:13EDGAR2Form 144 - Report of proposed sale of securities
21/8/202422:38EDGAR2Form 144 - Report of proposed sale of securities
21/8/202414:00GLOBECentessa Pharmaceuticals to Participate in the Morgan..
20/8/202422:52EDGAR2Form 144 - Report of proposed sale of securities
13/8/202413:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:15EDGAR2Form 8-K - Current report
13/8/202413:00GLOBECentessa Pharmaceuticals Reports Financial Results and..
10/6/202413:13EDGAR2Form 8-K - Current report
10/6/202413:00GLOBECentessa Pharmaceuticals Strengthens Executive Leadership..
21/5/202414:45GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
13/5/202422:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:23EDGAR2Form 8-K - Current report
13/5/202422:10GLOBECentessa Pharmaceuticals Reports Financial Results and..
09/5/202414:01EDGAR2Form ARS - Annual Report to Security Holders
09/5/202414:00EDGAR2Form DEF 14A - Other definitive proxy statements
Apertura: 18,28 Min: 16,95 Max: 18,33
Chiusura: 18,19

La tua Cronologia

NASDAQ
CNTA
Centessa Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network